300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Mobile
SaaS
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Climate
Infrastructure
Beauty
Fashion
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
LGBT
Android
Proptech
Impact
Sustainability
Cannabis
Hardware
Biotech
Transportation
Celebrity
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Singapore
Brazil
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Ireland
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Amadeus Capital Partners, VC Fund

Amadeus Capital Partners

VC Fund

Cambridge, United Kingdom

Amadeus Capital Partners is a VC fund in Cambridge focused on Software and Artificial Intelligence. Amadeus Capital is a global technology investor that invests in technology companies at all stages, from seed to venture buyout; they also buy stakes from other investors or founders, to ensure that companies and entrepreneurs have the runway they need to succeed. They invest in a broad variety of sectors including enterprise and infrastructuresoftware, consumer and business services, medical technology and healthcare IT, and cleantech and resource efficiency.It has the imagination to see where new businesses can be created and the technical insight, operational experience and global network to help entrepreneurs make their vision a reality.The Company was founded in 1997 and since has backed more than 130 companies and raised over $1bn for investment.

Total investments:
277
Last investment:
Lead investor:
32%
Fund size:
$85M
Last fund:

Last updated:

Industries Amadeus Capital Partners invests in

SoftwareArtificial IntelligenceInformation TechnologyMachine LearningBiotechnology

Stages Amadeus Capital Partners invests in

SeedSeries ASeries BSeries CFunding Round

Countries Amadeus Capital Partners invests in

United KingdomUnited StatesSpainBrazilSweden

Round sizes

Seed $800k–$9.2MSeries A $2.6M–$30MSeries B $7.2M–$56M

Contacts

NameEmailPhoneSocials
See all 9 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$800k–$9.2M
Series A
$2.6M–$30M
Series B
$7.2M–$56M

Investment Focus

Industry

  • Software 47 (17%)
  • Artificial Intelligence 27 (10%)
  • Information Technology 22 (8%)
  • Machine Learning 19 (7%)
  • Biotechnology 18 (6%)
See all 176 industries →

Stage

  • Seed 46 (17%)
  • Series A 45 (16%)
  • Series B 42 (15%)
  • Series C 30 (11%)
  • Funding Round 21 (8%)
See all 13 stages →

Country

  • United Kingdom 86 (31%)
  • United States 19 (7%)
  • Spain 7 (3%)
  • Brazil 3 (1%)
  • Sweden 3 (1%)
See all 17 countries →

Team

NameTitleInvestmentsLinksEmail
Amelia Armour
Amelia Armour Partner, Early Stage Funds
Partner, Early Stage Funds Total investments: 24
Find email
CEO Total investments: 8
Find email
Nick Kingsbury
Nick Kingsbury Partner
Partner Total investments: 20
Find email
Andrea Traversone
Andrea Traversone Managing Partner
Managing Partner Total investments: 18
Find email
Hermann Hauser
Hermann Hauser Co-founder, Director, and Venture Partner
Co-founder, Director, and Venture Partner Total investments: 102
Find email
See all 9 team members →

Investments

CompanyDescriptionRoundLinks
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia. $17.4M / Seed / Sep 02, 2026
Respiro Diagnostics develops non-invasive breath-based diagnostic tests focused on respiratory and oncology applications. The company builds a breath-based diagnostic platform that combines a proprietary collection device with molecular laboratory analysis to capture extracellular vesicles and other lung-derived biomarkers from exhaled breath. Itsinitial applications target earlier and more accurate detection of lung cancer and mesothelioma, with extension to other respiratory conditions and cancer research. Clinicians collect breath samples in minutes using the Respiro device and send them to the Respiro lab for high-resolution molecular profiling. The resulting reports are provided back to clinicians to support screening decisions, referrals, and treatment planning. Respiro Diagnostics also supports drug development and clinical research by generating rich molecular data from the lungs for use in studies and experimental therapies. $1.3M / Pre-Seed / Jul 08, 2026
SLAMcore’s mission is to make commercial-grade spatial intelligence accessible to allTheir team of world-leading spatial intelligence experts have developed advanced SLAM (simultaneous localization and mapping) software that allow robots and drones to truly understand the space around them.Spun out from Imperial College London, SLAMcore hascreated real-time, commercial grade, location, mapping and perception (SLAM) software for use in autonomous robots, drones and consumer products. The SLAMcore software enables fast prototyping and development of commercial products using visual SLAM software for autonomous location, mapping and perception. The software runs in real-time on standard compute/sensors and can be customised for commercial products using cost-effective custom compute/sensors. The team includes industry leading SLAM experts, roboticists, engineers and developers. Pushing the boundaries of what's possible today and how visual SLAM will look like tomorrow. Through partnership with OEMs, SLAMcore provides the core technology that allows robots to become a meaningful part of everyday life. $14M / May 27, 2026
Tenzo was created through the combination of data-science, software and deep restaurant operating experience.Tenzo was designed to reduce a reliance on gut: they can put data behind questions like how much food to order in, what member of staff to schedule at what time and whether to rerun a promotion.They bring deep expertise and a world classmanagement team - their co-founders have built successful multi-million pound businesses, and bring the best of data-science and technology from Cambridge, Harvard and McKinsey. $5M / Series A / Mar 31, 2026
Stateful is a mission control platform for mobile robots operating in dynamic environments - such as outdoors or alongside humans. We maximise value and robustness in real-world deployments for the next wave of robotics. The Stateful platform is hardware/robot agnostic and has been proven over multiple real-world deployments spanningquadrupeds carrying out high-hazard inspections, mobile service robots in security and care, and underwater robots collecting environmental data. $4.8M / Pre-Seed / Mar 24, 2026
Refute identifies and addresses misinformation on behalf of there businesses. $6.8M / Seed / Feb 03, 2026
Nu Quantum is a telecommunications company that develops end-to-end quantum cryptography systems.It secures communications within and between cities through urban and satellite free-space optical links. The system helps with the realization of commercial deliverable photonic technologies by combining novel materials and semiconductor technology.This enables clients to secure the exchange of cryptographic keys for the ultra-sensitive detection of light.Yuri Andersson, Mete Atatüre, and Carmen Berraquero founded Nu Quantum in Cambridge, Cambridgeshire in 2018. $71.1M / Series A / Dec 10, 2025
Sitehop is a technology company that develops cutting-edge cyber-security and networking solutions. Sitehop's custom FPGA solutions are used to optimize and accelerate cloud/telco networks. $10M / Series A / Oct 09, 2025
We build cutting-edge AI to directly address the real challenges faced in modern defence and national security. By partnering with key industry leaders, we deliver the next-generation defence technology that defines national strategic strength.Defence users deserve AI solutions built specifically for their needs, not generic enterprise models oroutdated custom tools that are a decade behind state-of-the-art AI.We are pioneering the “AI lab” model in defence, driving innovation that less specialised teams simply cannot match. Our work is grounded in the latest breakthroughs, but always with a clear focus: we don’t create general-purpose solutions. We design and deploy defence-first, frontier AI capabilities, unlocking strategic advantages where they matter most. $699.4K / Pre-Seed / Sep 04, 2025
Xampla creates plant protein material for commercial use. Our next generation material performs like synthetic polymers, but decomposes naturally and fully, without harming the environment. $14M / Series A / Sep 03, 2025
See all 277 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Mobile
SaaS
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Climate
Infrastructure
Beauty
Fashion
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
LGBT
Android
Proptech
Impact
Sustainability
Cannabis
Hardware
Biotech
Transportation
Celebrity
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Singapore
Brazil
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Ireland
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Amadeus Capital Partners invest in?

Amadeus Capital Partners invests primarily in Software, Artificial Intelligence and Information Technology startups, most often at Seed and Series A stage. Most of the 277 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Amadeus Capital Partners's check size?

Amadeus Capital Partners typically joins rounds of $800k–$9.2M at Seed, $2.6M–$30M at Series A and $7.2M–$56M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Amadeus Capital Partners participates in.

How do I contact Amadeus Capital Partners?

Public channels for Amadeus Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Amadeus Capital Partners?

The team at Amadeus Capital Partners includes Amelia Armour (Partner, Early Stage Funds), Anne Glover (CEO) and Nick Kingsbury (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Amadeus Capital Partners Amadeus Capital Partners Find emails